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Cutaneous 
Leishmaniasis 
Acquired in Jura, 
France
To the Editor: Cutaneous 
leishmaniasis is well established in 
the Mediterranean basin. However, 
the disease is spreading and new foci 
have been reported (1–3). Because 
of climate change, it is feasible 
that vector-borne diseases such as 
cutaneous leishmaniasis may spread 
northward into Europe (4). We report 
a patient who acquired cutaneous 
leishmaniasis while on holiday in 
Jura, France.
A previously healthy 49-year-
old white man from the Netherlands 
traveled to France in August 2007. 
During August 2–17, he stayed at 
a camp site in Clairvaux-les-Lacs 
in a forested area near a lake. He 
made regular trips by foot in the 
surrounding area. Three months later, 
he noticed a swelling on his nose. 
In February 2008, he consulted a 
dermatologist who treated him twice 
with cryotherapy under a diagnosis 
of actinic keratosis, after which the 
lesion nearly disappeared.
Three months later, the patient 
again consulted the dermatologist when 
the lesion recurred. A biopsy result 
from the lesion was interpreted as an 
acute ulcerative infl ammation without 
further specifi cation. Treatment was 
continued with imiquimod 5% cream 
followed by erythromycin 2% cream 
with clobetasol 0.05% ointment. 
Because of a lack of improvement, 
this treatment regimen was alternated 
with tacrolimus 0.1% ointment until 
May 2008.
In November 2008, he 
consulted another dermatologist, 
who obtained  a biopsy specimen in 
which a large number  of intracellular 
microorganisms compatible with 
leishmaniasis were observed in 
histiocytes. The patient was then 
referred to the Department of 
Dermatology at the Academic 
Medical Centre in Amsterdam. On 
examination, we found a plaque with a 
crusting surface and an erythematous 
border on the bridge of the nose 
(Figure, panel A). Regional lymph 
nodes were not palpable.
Revised histopathologic exam-
ination of the biopsy specimen showed 
a dermal infl ammatory infi ltrate of 
histiocytes containing numerous 
intracellular Leishmania amastigotes 
and epithelioid cells, lymphocytes, 
and few plasma cells (Figure, panel 
B). A direct smear from the biopsy 
specimen was positive for Leishman-
Donovan bodies. Culture on Novy-
MacNeal-Nicolle medium was 
positive for Leishmania spp. A PCR 
result for Leishmania performed on a 
biopsy specimen from the lesion was 
positive; sequence analysis showed 
DNA of Leishmania donovani/
infantum complex.
Treatment was initiated with oral 
itraconazole (100 mg, 2×/d) for 6 
weeks without improvement and was 
then continued with miltefosine (50 mg 
3×/d) for 28 days. Other than nausea, 
the patient did not experience side 
effects. Regular monitoring of liver 
function showed values within normal 
limits. The lesion healed completely.
There are several reports of 
leishmaniasis acquired in Europe in 
locations north of the Mediterranean 
basin. Naucke et al. (5) reported 
11 cases of endemically acquired 
leishmaniasis (human, canine, feline, 
and equine infections) in Germany 
since 1991. In 1992, a child with 
visceral leishmaniasis was described 
who had spent weekends and holidays 
near Calais, France (6).
We assume that our patient 
acquired cutaneous leishmaniasis in 
mainland Europe at 46°N. He had not 
visited leishmaniasis-endemic areas 
before this holiday in the French Jura.
Cutaneous leishmaniasis in 
France is found mainly in the region 
Pyrénées-Orientales, with 2 sandfl ies, 
Phlebotomus ariasi and Phlebotomus 
perniciosus, as vectors (7). One of the 
causative factors for the northward 
emergence of leishmaniasis in Europe 
is the spread of visceral and cutaneous 
leishmaniasis from disease-endemic 
areas in the Mediterranean to 
neighboring temperate areas with 
vectors without disease (8). A 
northward spread of leishmaniasis 
with an extension of the geographic 
range of Ph. perniciosus and Ph. 
neglectusus sandfl ies has been 
found in Italy (9), and northward 
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Figure. A) Crustosus plaque on the nose of the patient. B) The epidermis shows 
parakeratosis, atrophy, and a single apoptotic keratinocyte. An infl ammatory infi ltrate is 
present in the papillary dermis, mainly composed of (epithelioid) histiocytes, admixed with 
lymphocytes and few plasma cells. B) Most macrophages in the infi ltrate are parasitized 
by numerous Leishmania spp. amastigotes (hematoxylin and eosin stain, original 
magnifi cation ×400). A color version of this fi gure is available online (www.cdc.gov/EID/
article/18/01/11-0408-F1.htm). 
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spread of the proven sandfl y vector 
Ph. (Laroussius) perniciosus and 
the competent sandfl y vector Ph. 
(Transphlebotomus) mascittii into 
Germany (5). It has been hypothesized 
that sandfl ies have always been 
sporadically present in central 
Europe, but that climate change will 
lead to extended distribution (10).
It is tempting to assume that 
climate change resulted in cutaneous 
leishmaniasis at 46°N in France. In 
any event, our case and those reported 
by others should make clinicians 
aware of the possibility of cutaneous 
leishmaniasis outside the well-known 
disease-endemic areas.
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Visceral 
Leishmaniasis 
during Italian 
Renaissance, 
1522–1562
To the Editor: Leishmaniasis, an 
infectious disease caused by parasites 
of the genus Leishmania, is transmitted 
to humans through the bite of a female 
sandfl y. The 3 forms of leishmaniasis 
are visceral (VL) and cutaneous (CL), 
which are typical of the Old World, 
and mucocutaneous leishmaniasis, 
which occurs primarily in Central 
and South America. VL (also called 
kala-azar) is caused by species of the 
L. donovani complex (including L. 
infantum), and CL is mainly caused 
by L. major or L. tropica (1). In Italy, 
VL and CL are caused by L. infantum. 
The origin and spread of leishmaniasis 
are a matter of debate. Widespread 
in antiquity, visceral leishmaniasis 
has been identifi ed only in mummies 
from ancient Egypt and upper 
Nubia (2). Similarly, only 4 cases of 
mucocutaneous leishmaniasis have 
been identifi ed in skulls from northern 
Chile (3).
We describe the identifi cation of 
L. infantum infection in Eleonora from 
Toledo (1522–1562), wife of Cosimo 
I de’ Medici and member of one of 
the major political Italian families 
during the Renaissance. The positive 
identifi cation of Leishmania infection 
was achieved in bone samples by 
2 independent approaches. First, a 
molecular ancient DNA (aDNA) 
analysis identifi ed a specifi c 123-bp 
fragment of a conserved region of the 
minicircle molecule of the parasite´s 
kinetoplastid mitochondrial DNA 
(4,5) which on direct sequencing 
showed a Leishmania-specifi c 
sequence compatible with L. infantum 
(Figure; online Appendix Figure, 
wwwnc.cdc.gov/EID/article/18/1/10-
2001-FA1.htm). This PCR result 
was independently replicated in 2 
laboratories and additionally supported 
by the second approach, a protein 
assay showing a concomitant positive 
reaction by detecting IgG against L. 
infantum by Western blot sodium 
dodecyl sulfate–polyacrylamide gel 
electrophoresis.
Direct sequencing of the 
Leishmania aDNA identifi ed a 
strain with high homology to L. 
infantum. Accordingly, we obtained 
a 98% concordance rate between 
our sequence and that of L. infantum 
(expect rate 6e-47, identity rate 
113/118) (online Appendix Figure). 
The rates for other Leishmania species 
indicated that concordance for those 
species was less probable.
For the protein assay, fractionated 
proteins from a lysate of late-log-
phase promastigotes of L. infantum 
ZMON-1 (World Health Organization 
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